Using the information obtained in these PROMS can help to redesign, renew or refine services, improving the quality of health and social care.

MSK-HQ

The MSK-HQ is available for licencing through Oxford University Innovation. [1]

Since the publication[2] of its validation study in August 2016, a new partnership model for implementing the MSK-HQ across different services has been developed. The MSK-HQ itself and the implementation model serve as leading examples of how patient-reported measures could drive quality improvement within routine clinical practice.

This has led to a further grant awarded by ARUK[3][4], to Keele and Oxford Universities to develop and implement an electronic intervention which includes the MSK-HQ to support clinical care, further broadening its reach and impact across more services.

LTCQ

The LTCQ is already being used as an outcome measure in the NIHR-supported Feeling Safe Study[5] of management of schizophrenia and is being trialled for use in dementia services[6][7].

Several NHS trusts have expressed interest in its use for planning and evaluating services and the CLAHRC is currently in discussions with its host trust (Oxford Health NHs Foundation Trust) to explore embedding these measures into the STP’s in our region.



[1] https://innovation.ox.ac.uk/outcome-measures/musculoskeletal-health-questionnaire-msk-hq/

[2] Hill JC, Kang S, Benedetto E, Myers H, Blackburn S, Smith S, Dunn KM, Hay E, Rees J, Beard D, Glyn-Jones S. Development and initial cohort validation of the Arthritis Research UK Musculoskeletal Health Questionnaire (MSK-HQ) for use across musculoskeletal care pathways. BMJ open. 2016 Aug 1;6(8):e012331.

[3] http://www.arthritisresearchuk.org/research/grant-tracker-items/2017/aiming-for-patient-centred-treatment-through-use-of-the-arthritis-research-uk-musculoskeletal-health.aspx

[4] http://www.arthritisresearchuk.org/research/news-for-researchers/2017/march/health-services-research-awards-announced.aspx

[5] Freeman D, Waite F, Emsley R, Kingdon D, Davies L, Fitzpatrick R, Dunn G. The efficacy of a new translational treatment for persecutory delusions: study protocol for a randomised controlled trial (The Feeling Safe Study). Trials. 2016 Mar 11;17(1):134.

[6] http://www.hra.nhs.uk/news/research-summaries/patient-and-carer-well-being-in-memory-clinics/

[7] http://www.pssru.ac.uk/blogs/blog/living-with-long-term-conditions-validation-of-the-long-term-conditions-questionnaire-ltcq/